title: Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs.
authors.affiliation: Association pour l'Utilisation du Rein Artificiel, France. beatrice.viron@auraparis.org
authors.forename: Béatrice
authors.initials: B
authors.lastname: Viron
authors.forename: Claire-Antoinette
authors.initials: CA
authors.lastname: Dupuy
authors.forename: Amir
authors.initials: A
authors.lastname: Kolta
authors.forename: Nicole
authors.initials: N
authors.lastname: Casadevall
mesh_terms: D000369:Aged, 80 and over; D000068256:Darbepoetin alfa; D004351:Drug Resistance; D004921:Erythropoietin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000276:immunology / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced* / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D006397:Hematinics; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa